Peptide Reference

Lyophilisation: Why Peptides Arrive as Powder

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-232 cited sources

The short answer

Lyophilisation freezes a peptide solution then removes the ice by sublimation under vacuum, leaving a dry cake. Because water participates in peptide-bond hydrolysis and enables oxidation and deamidation, removing it removes the principal routes to degradation.

Key facts

Process
Freeze, then sublime under vacuum
Removes
Water, without passing through liquid
Why it works
Water participates in hydrolysis
Result
A porous cake
Still required
Cold, dry, dark storage
Reversed by
Reconstitution

Why sublimation rather than evaporation

Drying a peptide by evaporation would concentrate it progressively through increasingly viscous solution, exposing it to high local concentrations and heat. Sublimation goes from solid directly to vapour under vacuum, so the peptide is never in a concentrated liquid phase. That is gentler, and it is the reason freeze-drying is the standard rather than simply heating the solution.

What the cake is

The ice occupied space, and when it sublimes that space remains as pores. The result is a light, porous solid with a large surface area. That is why lyophilised peptide dissolves quickly when solvent is added, and why the cake can look like almost nothing in the bottom of a vial while containing the full stated quantity.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

What the cake's appearance tells you

A well-formed cake holds its shape. Collapse (a shrunken, glassy or melted-looking residue) indicates the material warmed above its critical temperature during drying or in transit, and it is associated with higher residual moisture and reduced stability. It is not proof of degradation, but it is a visible reason to be more careful.

Why cold storage is still needed

Freeze-drying removes most water but not all, and residual moisture supports slow hydrolysis. Oxidation of methionine and cysteine proceeds in the solid state too, driven by oxygen rather than water. Lyophilisation greatly slows degradation; it does not stop it, which is why the storage instruction persists after drying.

Why reconstitution is deliberately late

Adding solvent restores every degradation route lyophilisation removed. Solution-phase peptide is markedly less stable, which is why material is supplied dry, reconstituted immediately before use, aliquoted to avoid repeated freeze-thaw cycles, and not stored in solution longer than necessary.

Why freeze-thaw damages what freeze-drying protected

Repeated freezing and thawing is not the same as being frozen. Each cycle concentrates solutes at the advancing ice boundary and creates fresh ice-water interfaces, both of which destabilise peptides. Aliquoting into single-use volumes avoids the cycling entirely, and it is the single most effective handling step after reconstitution.

Frequently asked questions

Why does the vial look empty?

A lyophilised cake is porous and light. It can look like almost nothing while containing the full stated quantity.

What does a collapsed cake mean?

The material warmed above its critical temperature during drying or transit. Associated with higher residual moisture and reduced stability.

If it is dry, why keep it cold?

Residual moisture supports slow hydrolysis, and oxidation proceeds in the solid state. Drying slows degradation rather than stopping it.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More Peptide Reference articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.